RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $949.46 thousand as of August 15, 2025. Its market cap has increased by 23.71% in one year.

Market Cap

949.46K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 949.46K, a decrease of -96.40%. That is a compound annual growth rate of -9.50%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	949.46K	25.00%
Dec 31, 2024	759.57K	65.58%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.93M
Veradigm	798.20M
Tian'an Technology Group	628.15M
Glass House Brands	598.01M
Elite Pharmaceuticals	567.50M
American Oncology Network	389.51M
Northwest Biotherapeutics	351.78M
CytoDyn	336.73M

Market Cap Rankings